BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 3020463)

  • 1. [Clinicopathological study on malignant glioma--with special reference to GFAP].
    Tajika T; Kubo O; Tajika Y; Toyama T; Himuro H; Inoue N; Sakairi M; Kitamura K
    No Shinkei Geka; 1986 Jun; 14(7):831-5. PubMed ID: 3020463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
    Reyaz N; Tayyab M; Khan SA; Siddique T
    J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors.
    Chen Y; Zhang YX
    Acta Cytol; 1989; 33(6):922-8. PubMed ID: 2588925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunocytochemical comparison of the glia-associated proteins glial fibrillary acidic protein (GFAP) and S-100 protein (S100P) in human brain tumors.
    Kimura T; Budka H; Soler-Federsppiel S
    Clin Neuropathol; 1986; 5(1):21-7. PubMed ID: 3512139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primitive neuroectodermal tumors including the medulloblastoma: glial differentiation signaled by immunoreactivity for GFAP is restricted to the pure desmoplastic medulloblastoma ("arachnoidal sarcoma of the cerebellum").
    Herpers MJ; Budka H
    Clin Neuropathol; 1985; 4(1):12-8. PubMed ID: 3978900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunohistochemical study of S-phase cells in human gliomas].
    Ibayashi N; Hirakawa K; Suzuki K; Nakamura K; Houri T
    No To Shinkei; 1988 Aug; 40(8):763-9. PubMed ID: 2460117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of glial fibrillary acidic protein and protein S-100 in cerebral astrocytic gliomas of varying degrees of malignancy (immunohistochemical study)].
    Korshunov AG; Sycheva RV
    Arkh Patol; 1995; 57(4):30-8. PubMed ID: 8526753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum GFAP is a diagnostic marker for glioblastoma multiforme.
    Jung CS; Foerch C; Schänzer A; Heck A; Plate KH; Seifert V; Steinmetz H; Raabe A; Sitzer M
    Brain; 2007 Dec; 130(Pt 12):3336-41. PubMed ID: 17998256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic analysis of primary brain tumors.
    McComb RD; Burger PC
    Neurol Clin; 1985 Nov; 3(4):711-28. PubMed ID: 3001488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cytokeratins in gliomas.
    Goswami C; Chatterjee U; Sen S; Chatterjee S; Sarkar S
    Indian J Pathol Microbiol; 2007 Jul; 50(3):478-81. PubMed ID: 17883112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic alteration of glioma cells during culture.
    Imai F; Marunouchi T; Mizoguchi Y; Ogasawara M; Kanno T
    Noshuyo Byori; 1993; 10(1):19-25. PubMed ID: 8220779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-1-antichymotrypsin in human glioblastoma multiforme cells and its relation to GFAP immunostaining.
    Kroh H; Cervós-Navarro J
    Clin Neuropathol; 1991; 10(4):181-6. PubMed ID: 1653125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. J1-31 protein expression in astrocytes and astrocytomas.
    Shuangshoti S; Thorner PS; Ruangvejvorachai P; Saha B; Groshen S; Taylor CR; Malhotra S; Imam SA
    Neuropathology; 2009 Oct; 29(5):521-7. PubMed ID: 19019178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fascin expression in 90 patients with glioblastoma multiforme.
    Roma AA; Prayson RA
    Ann Diagn Pathol; 2005 Dec; 9(6):307-11. PubMed ID: 16308158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential immunohistochemical diagnosis of tumors of the human central nervous system using monoclonal antibodies].
    Vial'tseva IuIu; Bukhvalov IB; Vasilov RG
    Arkh Patol; 1996; 58(2):28-32. PubMed ID: 8712936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferritin in astrocytomas.
    Liu YF; Li Q; Yang P; Wang WL; Liu JA
    Chin Med J (Engl); 1991 Apr; 104(4):326-9. PubMed ID: 1648465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression.
    Wilhelmsson U; Eliasson C; Bjerkvig R; Pekny M
    Oncogene; 2003 May; 22(22):3407-11. PubMed ID: 12776191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The distribution of glial fibrillary acidic protein and protein S-100 in experimental brain tumors in rats].
    Khalanskiĭ AS; Shevchenko GM; Berezin VA
    Zh Vopr Neirokhir Im N N Burdenko; 1991; (1):19-22. PubMed ID: 1649519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gliosarcoma: a histologic and immunohistochemical reaffirmation.
    Meis JM; Ho KL; Nelson JS
    Mod Pathol; 1990 Jan; 3(1):19-24. PubMed ID: 2155418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of immunohistochemistry in neuro-oncology. I. Demonstration of glial fibrillary acid protein (GFAP) in extracranial metastases from primary brain tumors].
    Gottschalk J; Martin H; Kretschmer B; Barz H; Janda J; Szymas J
    Zentralbl Allg Pathol; 1985; 130(5):391-6. PubMed ID: 3913231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.